Medindia

X

Abaxis, Inc. to Present at the UBS Global Life Sciences Conference

Tuesday, September 16, 2008 General News J E 4
Advertisement
UNION CITY, Calif., Sept. 16 Abaxis, Inc.(Nasdaq: ABAX), a medical products company manufacturing point-of-care bloodanalysis systems, announced today that Clint Severson, CEO and President, willpresent at the UBS Global Life Sciences Conference on Monday, September 22,2008 at 8:30 a.m. EDT, at the Grand Hyatt New York in New York City.

Interested parties can access the webcast of the presentation athttp://www.ibb.ubs.com. Click on the conferences icon, then click on the 2008Global Life Sciences Conference event and follow the link for the webcast. Thereplay will be available 3 hours after the actual presentation time, and willbe accessible until October 25, 2008.

About Abaxis

Abaxis develops, manufactures and markets portable blood analysis systemsfor use in any veterinary or human patient-care setting to provide clinicianswith rapid blood constituent measurements. The system consists of a compact,5.1 kilogram (11.2 pounds), portable analyzer and a series of single-useplastic discs, called reagent discs that contain all the chemicals required toperform a panel of up to 13 tests on veterinary patients and 14 tests on humanpatients. The system can be operated with minimal training and performsmultiple routine tests on whole blood, serum or plasma samples. The systemprovides test results in less than 12 minutes with the precision and accuracyequivalent to a clinical laboratory analyzer.Contact: Clint Severson Lytham Partners, LLC Chief Executive Officer Joe Dorame, Joe Diaz & Robert Blum ABAXIS, Inc. 602-889-9700 510-675-6500

SOURCE Abaxis, Inc.
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
California's Proposition 5 Could Significantly Boo...
S
ISMP and iGuard.org Partner to Increase Medication...